Kok-Jensen A - Search Results

1

Risk of hospital admission for obstructive pulmonary disease in alpha(1)-antitrypsin heterozygotes of phenotype PiMZ.

Seersholm N, Wilcke JT, Kok-Jensen A, Dirksen A. Seersholm N, et al. Am J Respir Crit Care Med. 2000 Jan;161(1):81-4. doi: 10.1164/ajrccm.161.1.9812131. Am J Respir Crit Care Med. 2000. PMID: 10619801

2

Patient-administered sequential spirometry in healthy volunteers and patients with alpha 1-antitrypsin deficiency.

Madsen F, Ulrik CS, Dirksen A, Hansen KK, Nielsen NH, Frølund L, Viskum K, Kok-Jensen A. Madsen F, et al. Respir Med. 1996 Mar;90(3):131-8. doi: 10.1016/s0954-6111(96)90154-7. Respir Med. 1996. PMID: 8736204 Free article.

3

Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group.

Seersholm N, Wencker M, Banik N, Viskum K, Dirksen A, Kok-Jensen A, Konietzko N. Seersholm N, et al. Eur Respir J. 1997 Oct;10(10):2260-3. doi: 10.1183/09031936.97.10102260. Eur Respir J. 1997. PMID: 9387950 Free article. Clinical Trial.

4

Intermediate alpha 1-antitrypsin deficiency PiSZ: a risk factor for pulmonary emphysema?

Seersholm N, Kok-Jensen A. Seersholm N, et al. Respir Med. 1998 Feb;92(2):241-5. doi: 10.1016/s0954-6111(98)90102-0. Respir Med. 1998. PMID: 9616519 Free article.

5

Clinical features and prognosis of life time non-smokers with severe alpha 1-antitrypsin deficiency.

Seersholm N, Kok-Jensen A. Seersholm N, et al. Thorax. 1998 Apr;53(4):265-8. doi: 10.1136/thx.53.4.265. Thorax. 1998. PMID: 9741368 Free PMC article.

6

Reversible and irreversible airflow obstruction as predictor of overall mortality in asthma and chronic obstructive pulmonary disease.

Hansen EF, Phanareth K, Laursen LC, Kok-Jensen A, Dirksen A. Hansen EF, et al. Am J Respir Crit Care Med. 1999 Apr;159(4 Pt 1):1267-71. doi: 10.1164/ajrccm.159.4.9807121. Am J Respir Crit Care Med. 1999. PMID: 10194175

7

Transmitting genetic risk information in families: attitudes about disclosing the identity of relatives.

Wilcke JT, Seersholm N, Kok-Jensen A, Dirksen A. Wilcke JT, et al. Am J Hum Genet. 1999 Sep;65(3):902-9. doi: 10.1086/302531. Am J Hum Genet. 1999. PMID: 10441594 Free PMC article.

8

A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy.

Dirksen A, Dijkman JH, Madsen F, Stoel B, Hutchison DC, Ulrik CS, Skovgaard LT, Kok-Jensen A, Rudolphus A, Seersholm N, Vrooman HA, Reiber JH, Hansen NC, Heckscher T, Viskum K, Stolk J. Dirksen A, et al. Am J Respir Crit Care Med. 1999 Nov;160(5 Pt 1):1468-72. doi: 10.1164/ajrccm.160.5.9901055. Am J Respir Crit Care Med. 1999. PMID: 10556107 Clinical Trial.

9

Attitudes toward an unsolicited approach in relation to status of genetic disease: exemplified by alpha(1)-antitrypsin deficiency.

Wilcke JT, Seersholm N, Kok-Jensen A, Dirksen A. Wilcke JT, et al. Am J Med Genet. 2000 Sep 18;94(3):207-13. doi: 10.1002/1096-8628(20000918)94:3<207::aid-ajmg6>3.0.co;2-u. Am J Med Genet. 2000. PMID: 10995507

10

Peak flow as predictor of overall mortality in asthma and chronic obstructive pulmonary disease.

Hansen EF, Vestbo J, Phanareth K, Kok-Jensen A, Dirksen A. Hansen EF, et al. Am J Respir Crit Care Med. 2001 Mar;163(3 Pt 1):690-3. doi: 10.1164/ajrccm.163.3.2006120. Am J Respir Crit Care Med. 2001. PMID: 11254525

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

98 results

Search Page

Filters